Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin

Neoplasia

Volumn 3, Issue 4, 2001, Pages 360-367

  Zellweger, Tobias ^a,b   Miyake, Hideaki ^a,b   July, Laura V ^a,b   Akbari, Majid ^a,b   Kiyama, Satoshi ^a,b   Gleave, Martin E ^a,b  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Antisense clusterin oligonucleotides; Caki 2; Paclitaxel; Renal cell cancer

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CLUSTERIN; DNA FRAGMENT; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; PACLITAXEL;

ADOLESCENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SEQUENCE; DRUG EFFECT; DRUG SENSITIZATION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOUSE; NICK END LABELING; NONHUMAN; NORTHERN BLOTTING; NUDE MOUSE; PRIORITY JOURNAL;

EID: 0034870685     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900174     Document Type: Article

References (31)

1. Renal cell carcinoma
2. Epidemiologic aspects of renal cell cancer
3. Chemotherapy for advanced renal-cell carcinoma: 1983-1993
4. Systemic therapy for renal cell carcinoma
5. Therapeutic applications of oligonucleotides
6. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against c-raf kinase
7. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxy-nucleotides
8. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence
9. Antisense Bcl-2 oligodeoxynucleotides inhibit progression to androgen-independence after castration in the Shionogi tumor model
10. Antitumor activity of a C-raf antisense oligodeoxynucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted subcutaneously into nude mice
11. Bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice
12. Growth inhibition of DU-145 prostate cancer cells by a Bcl-2 antisense oligodeoxynucleotide is enhanced by N-(2-hydroxyphenyl) all-trans retinamide
13. Chemosensitization and delayed androgen-independent recurrence of prostate cancer with the use of antisense Bcl-2 oligodeoxynucleotides
14. Purification and characterization of a cell-aggregating factor (clusterin), the major glycoprotein in ram rete testis fluid
15. Clusterin: Physiologic and pathophysiologic considerations
16. Clusterin and the kidney
17. Gp80 (clusterin; TRPM-2) mRNA level is enhanced in human renal clear cell carcinomas
18. Clusterin: An enigmatic protein recruited by diverse stimuli
19. Clusterin has chaperone-like activity similar to that of small heat shock proteins
20. Paclitaxel (Taxol)
21. Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models
22. Polymeric micellar paclitaxel induces tumor regression in androgenindependent prostate cancer in the LNCaP tumor model
23. Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer
24. Acceleration of human prostate carcinoma growth in vivo by factors produced by prostate and bone fibroblasts
25. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
26. Combination photoimmunotherapy and ciplatin: Effects on human ovarian cancer ex vivo
27. Hormonal and chemotherapy of renal cell carcinoma
28. Immunotherapy for metastatic renal cell carcinoma
29. Interferon gamma-1b compared with placebo in metastatic renal cell carcinoma
30. Antisense testosterone-repressed prostate message-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo
31. Expression of clusterin in human renal diseases